SIGMA Healthcare announced the release of CarePro at the 2018 Amcal and Guardian Retail Conference currently underway on the Gold Coast.
Carepro is a program developed by health data and patient insight specialist NostraData.
The CarePro platform will allow pharmacists to manage patient health care in a secure way to provide better advice and offer additional professional services with populated doctor referrals and patient summaries ensuring a seamless continuity of care.
The platform uses unique web-based technology that analyses patient medication history across NostraData's complete secure network, and is intelligent enough to notify the pharmacist if a patient is eligible for additional professional service assistance based on their medication history.
Amcal & Guardian general manager retail Brian Tomlin said the new and innovative patient support program backed by industry leading partners "ensures pharmacists can support patients who have complex therapies and conditions".
For example, he said, the platform could be used to perform diabetes risk assessments and support Amcal and Guardian's in-pharmacy HbA1C testing.
"CarePro allows for consistent, professional and measurable services delivery by a pharmacy."
Described as a game-changer for the pharmacy-customer interface, the CarePro technology will not only assist with comprehensive patient care but also ensure its data security and effectiveness, he said.
NostraData director and chief operating officer Mike da Gama said his company creates unique algorithms to support each patient-centric program.
"These algorithms can be run against connected dispense databases and then notify the pharmacist which of their patients would be eligible for an individual professional service," da Gama said.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 May 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 May 18
